Prudential Financial
DNTH icon

Prudential Financial’s Dianthus Therapeutics DNTH Stock Holding History

Prudential Financial’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
18,591
+465
+3% +$40.6K ﹤0.01% 1437
2026
Q1 		$1.52M Buy
+18,126
New +$1.05M ﹤0.01% 1435
2020
Q4 		– Sell
-1,176
Closed -$128K – 2460
2020
Q3 		$128K Buy
+1,176
New +$139K ﹤0.01% 2348

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Prudential Financial's DNTH Position: Q2 2026 in Review

Prudential Financial increased its Dianthus Therapeutics (DNTH) stake by 2.6% in Q2 2026, buying an estimated $40.6K and bringing the position to 18,591 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1437.

Prudential Financial first reported a position in DNTH in Q3 2020 and has held it in 3 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Prudential Financial held 18,591 shares of Dianthus Therapeutics worth $1.81M as of Q2 2026.
  • Prudential Financial bought 465 Dianthus Therapeutics shares in Q2 2026, an estimated $40.6K.
  • Dianthus Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1437 holding.
  • Prudential Financial first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 3 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.